ABSTRACT
Objective@#To understand the effect of treating obstructive sleep apnea hypopnea syndrome (OSAHS) on chronic cough in children.@*Methods@#A total of 100 consecutive children with OSAHS diagnosed by polysomnography(PSG) and chronic cough were included in this study. All children underwent cough condition assessment, OSA-18 scales and MS-IOS before and after surgery, and all children were followed-up for 3 months. Children were separated into three groups according to the severity of OSAHS. Related parameters like Zr, Rf, R5, R20, X5, X35, Rc, Rp obtained from MS-IOS, OSA-18 scores and cough scores were compared between different groups using paired t-test or Wilcoxon sum test.@*Results@#There existed significantly positive correlations between AHI and scores of OSA-18(r=0.653, P<0.01). AHI positively related to cough scores including diurnal(r=0.470, P<0.01)and nocturnal cough scores(r=0.459, P<0.01). Scores of OSA-18 had similarity in correlations with diurnal(r=0.527, P<0.01)and nocturnal cough scores(r=0.532, P<0.01). All children got improved in OSA-18 scales and cough scores after treatment. In details, the three groups were mild group(n=34), moderate group(n=37), severe group(n=29). OSA-18 scales decreased dramatically in each group after surgery, Z values were -5.014, -5.035, -4.624 respectively(P=0.000). Cough scores in day and night got reduced after treatment, Z values were -5.112, -5.102, -5.394, -5.374, -4.777, -4.770 in three groups. Rp in all children got alleviated after surgical management, Z were -3.150, -5.035, -5.374(P=0.000). Other parameters were analyzed using paired t test. Z5, R5, R20, R35 got reduced in all three groups.X5 got reduced in mild and moderate groups. Rc reduced only in the moderate group.@*Conclusions@#OSAHS may be a trigger or inducer of chronic cough. Active treatment of OSAHS via surgery can improve the quality of children′s life and alleviate the symptoms of cough in day and night.
ABSTRACT
Objective To study effect of Shikonin on human cervical cancer Hela cell growth suppression in vitro and its mechanism. Methods MTT assay was used to examine the growth inhibition of Shikonin in Hela cells.And then, the measurement of both ROS Levels and Mitochondrial Membrane Potential (ΔΨm ) were performed to clarify the mechanism of antitumor in Hela cells by Shikonin.Results Shikonin significantly inhibited the growth of Hela cells in a concentration-dependent manner.Shikonin increased generation of en-dogenous reactive oxygen species ( ROS) and decreased mitochondrial membrane potential.Furthermore, anti-oxidants N-acetylcysteine ( NAC) could significantly reduce the antitumor activity of SK in Hela cells.Conclusion These results suggest that mitochondrial aerobic respiration shift and endogenous ROS augmentation contribute to the action of Shikonin against Hela cells.
ABSTRACT
Objective To investigate the destructive effect of CSC-DC-CIK who were induced by cytokine induced killer (CIK) cells co-cultured with dendritic cells (DCs) on homologous tumor cells and to explore the possibility of CSC anti-gen involving in killing tumor. Methods Kidney cancer stem cells (KSCs) and lung cancer stem cells (LSCs) were isolated through FACS using CD133 +as a selection marker from cultured kidney cancer cell line A498 and lung cancer cell line A549 respectively. Freeze-thaw method was used to obtain the cancer stem cells(CSCs)antigens. DC cells and CIK cells were collected by in vitro expansion and inducted from the mononuclear cells isolated from human cord blood. The CIK cells were co-cultured with the DCs which were pulsed with the CSCs antigens(CSC-DC-CIK)mentioned above. Immunopheno-types of DC and CIK were analyzed by flow cytometry;cytokines levels were detected by ELISA kits and the destructive ef-fects of two kinds of CSC-DC-CIKs were tested by lactate dehydrogenase (LDH) release assay. Results The expression of phenotypes CD40+, CD80+, CD86+and HLA-DR+were higher in CSC-DC than in CD(P<0.01);the expression of pheno-types CD40+, CD80+, CD86+and HLA-DR+of DC and CSC-DC were higher after co-culture than those before co-culture( P<0.01);the expression of phenotypes CD40+, CD80+, CD86+and HLA-DR+of CSC-DC after been co-cultured with CIK were higher than those of DC after been co-cultured with CIK(P<0.01). The CIK phenotypes:CD3+, CD8+, CD56+were in-creased in CIK co-cultured with both CSC-DC and DC than those before co-culture (P<0.01);the expression of pheno-types CD3+, CD8+, CD56 +were higher in CSC-DC co-cultured with CIK than in DC co-cultured with CIK. DC-CIK and CSC-DC-CIK groups were more capable to express IFN-γ, TNF-α, IL-2 than they were before co-cultured with CIK (P<0.01). CSC-DC-CIK group can secrete more above cytokines than DC-CIK group does(P<0.01). The destructive rates of KSC-DC-CIK and LSC-DC-CIK on target cells were (50.21 ± 4.24)%and (49.32 ± 3.89)%respectively which were much higher than that in DC-CIK(30.25±3.11)%(F=89.157,P<0.01). Conclusion CSC-DC-CIKs have destructive effects on homologous tumor cells. More researches are needed to explore the mechanism and to evaluate the clinical applications.
ABSTRACT
<p><b>OBJECTIVE</b>The aim of this study was to understand the effect of different treatment of obstructive sleep apnea-hypopnea syndrome (OSAHS) for refractory asthma in children.</p><p><b>METHODS</b>Fifty two children (32 in surgical group, 20 in conservative group) with refractory asthma and OSAHS were included in the study. All children received asthma condition assessment and polysomnography (PSG) examination before and after treatment, and were followed up for 6 months.</p><p><b>RESULTS</b>All children got improved in PSG values 3 months after treatment, more significant improvement was achieved in surgical group than in conservative group (P < 0.05). While compared of OSAHS treatment, there were 2 cure, 6 notable effective, 9 effective, 3 in vain cases in conservative group, 8 cure, 16 notable effective, 8 effective, 0 in vain cases in surgery group. There was significant difference between the two groups (χ² = 8.91, P = 0.031). All children got improved in asthma condition evaluation parameters and decreased the use number of short acting β2 agonists after 6 months treatment. More significant improvement was achieved in surgical group than in conservative group. The differences of all the items had statistical significance (P < 0.05). There was statistical correlation between days mutation rate of peak expiratory flow (PEF) and apnea hypopnea index (r = 0.712, P < 0.01), and between days mutation rate of PEF and lowest oxygen saturation (r = 0.726, P < 0.01).</p><p><b>CONCLUSIONS</b>Active treatment of OSAHS can improve asthma symptoms and reduce asthma medication effectively. The curative effect of surgical treatment is superior to conservative treatment.</p>
Subject(s)
Child , Child, Preschool , Female , Humans , Male , Adenoidectomy , Asthma , Drug Therapy , General Surgery , Sleep Apnea, Obstructive , Drug Therapy , General Surgery , TonsillectomyABSTRACT
<p><b>OBJECTIVE</b>To disclose the etiological factors and to investigate the therapeutical effect on nasal disorders in 128 children with intractable cough.</p><p><b>METHODS</b>One hundred and twenty-eight children with intractable cough were consulted by ENT doctors using electronic nasopharyngoscope, for those children with nasal diseases, relevant treatment was given.</p><p><b>RESULTS</b>Among 128 children, one hundred and sixteen had nasal disorders. Upper airway cough syndrome (UACS) was diagnosed in 92 cases (71.9%), nasal disorders without UACS was diagnosed in 24 cases (18.7%), no nasal disorders were found in 12 cases (9.4%). Among children with UACS, allergic rhinitis was diagnosed in 76 cases, rhino-sinusitis in 39 cases, adenoid hypertrophy in 54 cases, and chronic rhinitis in 8 cases. However, for those children without UACS, 10 cases had chronic rhinitis and 14 cases had allergic rhinitis. Clinical symptoms, signs and the findings of electronic nasopharyngoscope were analyzed in 92 children with UACS. The results showed that regular cough occurred in 62 cases, nasal disease in 65 cases, subjective feeling of postnasal discharge in 18 cases, mouth breathing or snoring in 32 cases, purulent secretion in nasal meatus in 61 cases, retropharyngeal folliculosis in 58 cases, purulent secretion in pharynges detected from pharynx in 41 cases, and purulent or viscosity secretion were found in 91 cases by first electronic nasopharyngoscopy. After 14 days of treatment, the children with UACS (90/92) had significant higher remission rate (chi² = 32.21, P = 0.000) in cough than those who had nasal disorders but without UACS (13/24).</p><p><b>CONCLUSIONS</b>The nasal disorders, especially for UACS, were common in children with intractable cough. The therapy to nasal disorders could release the chronic cough symptoms in children with intractable cough.</p>
Subject(s)
Adolescent , Child , Child, Preschool , Female , Humans , Male , Chronic Disease , Cough , Rhinitis , TherapeuticsABSTRACT
<p><b>OBJECTIVE</b>To analyze clinical features of pediatric rhino-source diseases for reducing missed diagnosis and misdiagnosis.</p><p><b>METHOD</b>Data of 3588 children with rhino-source diseases seen from April 2005 to May 2006 were retrospectively analyzed in this study in order to disclose the relationship of etiological factor, clinical features and diagnosis.</p><p><b>RESULT</b>Among all these cases, 2090 complained of nasal discomfort including nasal obstruction, discharge, rhinalgia and epistaxis. However 1498 cases (41.76%) did not, of whom 470 cases had snoring and apnea, 332 cases of otalgia and otorrhea, 145 cases had chronic cough, 138 had headache and 92 had lower respiratory infection.</p><p><b>CONCLUSION</b>A high percentage of children who suffered from pediatric rhino-source disease did not develop nasal symptoms. Pediatric rhino-source disease should be considered for patients in whom the therapeutic effect is unexpectedly poor.</p>